Oral Session

[O-45] Neurogenetics/ Gene therapy (Clinical research)

Sat. May 26, 2018 10:15 AM - 11:45 AM Room 8 (Royton Sapporo / Empress Hall （2F）)

Chair：Shin-ichi Muramatsu（Division of Neurology, Department of Medicine, Jichi Medical University）Commentator：Kinji Ohno（Neurogenetics, Nagoya University Graduate School of Medicine）

+Add all to schedule

[O-45-1] A familial case of PDE10A-associated childhood-onset chorea with bilateral striatal lesions

^○Satoko Miyatake^1,2, Ikuko Shirai³, Satoko Kumada³, Yasuhiro Nakata⁴, Naomichi Matsumoto² (1.Clinical Genetics Department, Yokohama City University Hospital, 2.Department of Human Genetics, Yokohama City University Graduate School of Medicine, 3.Department of Neuropediatrics, Tokyo Metropolitan Neurological Hospital, 4.Department of Neuroradiology, Tokyo Metropolitan Neurological Hospital)

[O-45-2] Difference of genetically aggregated tissue specific networks between Japanese and Caucasian MS

^○Takuya Matsushita¹, Yuri Nakamura¹, Koji Shinoda¹, Mitsuru Watanabe¹, Noriko Isobe², Jun-ichi Kira¹, the Japan Multiple Sclerosis Genetics Consortium¹ (1.Department of Neurology, Graduate School of Medical Sciences, Kyushu University, 2.Department of Neurological Therapeutics, Graduate School of Medical Sciences, Kyushu University)

[O-45-3] Genotype-phenotype analysis of Japanese familial ALS pedigrees with SOD1 mutations

^○Ayumi Nishiyama¹, Naoki Suzuki¹, Hitoshi Warita¹, Rumiko Izumi¹, Naoko Shimakura¹, Tetsuya Akiyama¹, Shion Osana¹, Masaaki Kato¹, Tetsuya Niihori², Yoko Aoki², Masashi Aoki¹ (1.Department of Neurology, Tohoku University Graduate School of Medicine, 2.Department of Medical Genetics, Tohoku University School of Medicine)

[O-45-4] Validation of genetic factors affecting survival in Japanese ALS patients

^○Ryoichi Nakamura¹, Naoki Atsuta¹, Genki Tohnai¹, Masahiro Nakatochi¹, Naoki Hayashi¹, Daichi Yokoi¹, Hirohisa Watanabe¹, Masahisa Katsuno¹, Yuishin Izumi², Mitsuya Morita³, Akira Taniguchi⁴, Nobutaka Hattori⁵, Osamu Kano⁶, Masaya Oda⁷, Koji Abe⁸, Satoshi Kuwabara⁹, Kouichi Mizoguchi¹⁰, Ryuji Kaji², Gen Sobue¹, JaCALS^1,2,3,4,5 (1.Nagoya University, 2.Tokushima University, 3.Jichi Medical University, 4.Mie University, 5.Juntendo University, 6.Toho University Omori Medical Center, 7.Vihara Hananosato Hospital, 8.Okayama University, 9.Chiba University, 10.National Hospital Organization Shizuoka Medical Center)

[O-45-5] The pathological role of P413L variant chromogranin B in female amyotrophic lateral sclerosis

^○Yasuyuki Ohta^1,2, Genevieve Soucy², Daniel Phaneuf², Jean-nicolas Audet², Francois Gros-louis², Toru Yamashita¹, Kota Sato¹, Mami Takemoto¹, Jingwei Shang¹, Nozomi Hishikawa¹, Jean-pierre Julien², Koji Abe¹ (1.Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan, 2.Research Centre of Institut universitaire en santé mentale de Québec, Québec, Canada)

[O-45-6] Parent-of-origin effects in Multiple Sclerosis

^○Noriko Isobe¹, Andy Tsai², Stacy J. Caillier³, Adam Santaniello³, Jun-ichi Kira⁴, Stephen L. Hauser³, Jorge R. Oksenberg³ (1.Department of Neurological Therapeutics, Graduate School of Medical Sciences, Kyushu University, 2.Computational Biology and omputer Science, Massachusetts Institute of Technology, 3.Department of Neurology, University of California, San Francisco, 4.Department of Neurology, Graduate School of Medical Sciences, Kyushu University)